Number of the records: 1
Prodrug compositions and utility of hydroxamate-based GCPII inhibitors
- 1.
SYSNO ASEP 0544774 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title Prodrug compositions and utility of hydroxamate-based GCPII inhibitors Author(s) Slusher, B. S. (US)
Rais, R. (US)
Vávra, Jan (UOCHB-X) RID
Tichý, Tomáš (UOCHB-X) RID
Majer, Pavel (UOCHB-X)
Jančařík, Andrej (UOCHB-X) ORCID, RID
Tenora, Lukáš (UOCHB-X) ORCIDYear of issue 2021 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. US11059775 Date of the patent acceptance 13.07.2021 Name of the patent owner The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i Code of the issuer name US001 - United States Patent and Trademark Office (USPTO) Alexandria Current use A - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem Language eng - English Keywords hydroxamate ; prodrugs ; GCPII inhibitors OECD category Organic chemistry Institutional support UOCHB-X - RVO:61388963 Annotation Prodrugs of hydroxamate-based GCPII inhibitors and methods of their use for treating a disease or condition are disclosed. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418 Year of Publishing 2022 Electronic address https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=11059775B2&KC=B2&FT=D&ND=4&date=20210713&DB=&locale=en_EP
Number of the records: 1